TB Research

Melting the <i>eis</i>: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New <i>eis</i> Promoter Variants

Ley SD, Pillay S, Streicher EM, van der Heijden YF, Sirgel F, Derendinger B, de Kock M, Gagneux S, et al. (11 authors)

Antimicrobial agents and chemotherapy · 2021-06

Abstract

Eis promoter mutations can confer reduced Mycobacterium tuberculosis kanamycin susceptibility. GenoType MTBDR sl, a widely used assay evaluating this region, wrongly classified 17/410 isolates as eis promoter wild type. Six out of seventeen isolates harbored mutations known to confer kanamycin resistance, and the remainder harbored either novel eis promoter mutations (7/11) or disputed mutations (4/11). GenoType MTBDR sl can miss established and new variants that cause reduced susceptibility. These data highlight the importance of reflex phenotypic kanamycin testing.

MeSH terms

  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis, Multidrug-Resistant
  • Kanamycin
  • Antitubercular Agents
  • Diagnostic Tests, Routine
  • Microbial Sensitivity Tests
  • Drug Resistance, Multiple, Bacterial
  • Kanamycin Resistance
  • Genotype
  • Mutation